These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10934568)

  • 21. Tardive dyskinesia: a concern for the pediatrician.
    Singer HS
    Pediatrics; 1986 Apr; 77(4):553-6. PubMed ID: 2870466
    [No Abstract]   [Full Text] [Related]  

  • 22. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing effector pattern of tardive dyskinesia during the course of neuroleptic withdrawal.
    Newell KM; Wszola B; Sprague RL; Mahorney SL; Bodfish JW
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):262-8. PubMed ID: 11534536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia presenting as severe dysphagia.
    Gregory RP; Smith PT; Rudge P
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1203-4. PubMed ID: 1479401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case study: worsening Tourette's disorder or withdrawal dystonia?
    Mennesson M; Klink BA; Fortin AH
    J Am Acad Child Adolesc Psychiatry; 1998 Jul; 37(7):785-8. PubMed ID: 9666635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia and intellectual disability: an examination of demographics and topography in adults with dual diagnosis and atypical antipsychotic use.
    Fodstad JC; Bamburg JW; Matson JL; Mahan S; Hess JA; Neal D; Holloway J
    Res Dev Disabil; 2010; 31(3):750-9. PubMed ID: 20207106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive tremor.
    Stacy M; Jankovic J
    Mov Disord; 1992; 7(1):53-7. PubMed ID: 1348352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric properties of the Dyskinesia Identification System: Condensed User Scale (DISCUS).
    Sprague RL; Kalachnik JE; Slaw KM
    Ment Retard; 1989 Jun; 27(3):141-8. PubMed ID: 2739567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Algorithms for neuroleptic-associated tardive movement disorders.
    Akiyama K
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S23-9. PubMed ID: 10560894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive tourettism after exposure to neuroleptic therapy.
    Bharucha KJ; Sethi KD
    Mov Disord; 1995 Nov; 10(6):791-3. PubMed ID: 8749999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia.
    Glazer WM; Hafez H
    Schizophr Res; 1990; 3(5-6):315-20. PubMed ID: 1980827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
    Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
    Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin conductance responding in schizophrenic patients with abnormal involuntary movements.
    Mintz M; Alfisi S; Sigal M
    Psychiatry Res; 1990 Oct; 34(1):19-27. PubMed ID: 1980017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.